Inhibition of transplasma membrane electron transport by transferrin-adriamycin conjugates

  • Sun I
  • Sun E
  • Crane F
 et al. 
  • 3


    Mendeley users who have this article in their library.
  • 34


    Citations of this article.


Transplasma membrane electron transport from HeLa cells, measured by reduction of ferricyanide or diferric transferrin in the presence of bathophenanthroline disulfonate, is inhibited by low concentrations of adriamycin and adriamycin conjugated to diferric transferrin. Inhibition with the conjugate is observed at one-tenth the concentration required for adriamycin inhibition. The inhibitory action of the conjugate appears to be at the plasma membrane since (a) the conjugate does not transfer adriamycin to the nucleus, (b) the inhibition is observed within three minutes of addition to cells, and (c) the inhibition is observed with NADH dehydrogenase and oxidase activities of isolated plasma membranes. Cytostatic effects of the compounds on HeLa cells show the same concentration dependence as for enzyme inhibition. The adriamycin-ferric transferrin conjugate provides a more effective tool for inhibition of the plasma membrane electron transport than is given by the free drug. © 1992.

Author-supplied keywords

  • (HeLa cell)
  • Adriamycin-transferrin conjugate
  • Antitumor drug
  • Electron transport
  • NADH oxidase
  • Plasma membrane
  • Transferrin-adriamycin conjugate

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text


  • I. L. Sun

  • E. E. Sun

  • F. L. Crane

  • D. J. Morré

  • W. P. Faulk

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free